Complete Filing Data
Hamilton Insurance Group, Ltd. reported Common Stock Shares Outstanding of 99.03 million shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Hamilton Insurance Group, Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $278.9M | $271.1M | $259.9M | $177.7M | $15.7M | $15.2M |
| Income Tax Expense Benefit | -$15.1M | $8.4M | -$25.1M | $3.1M | $1.3M | $664.0K |
| Revenues | $2.91B | $2.33B | $1.57B | $1.23B | $64.0M | |
| Profit Loss | $840.0M | $613.2M | $280.3M | -$29.9M | -$35.9M | |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | $576.7M | $400.4M | $258.7M | -$98.0M | -$35.9M | |
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | $263.4M | $212.7M | $21.6M | $68.1M | -$3.0K | |
| Interest Expense | $20.2M | $22.6M | $21.4M | $15.7M | $1.1M | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $824.9M | $621.6M | $255.2M | -$26.8M | -$34.6M | |
| Amortization Of Intangible Assets | $15.7M | $15.5M | $10.8M | $12.8M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $74.3M | $68.8M | $62.7M | $62.4M | $64.9M | $54.9M | $63.0M | $49.2M | $45.8M | $46.3M |
| Income Tax Expense Benefit | $3.9M | $2.7M | $3.2M | $3.0M | $2.5M | $592.0K | $2.4M | $2.9M | $1.6M | $1.1M |
| Revenues | $667.7M | $740.8M | $768.8M | $512.8M | $587.9M | $658.6M | $396.3M | $357.2M | $322.4M | $226.9M |
| Profit Loss | $176.4M | $267.8M | $181.3M | $61.0M | $200.4M | $277.3M | $52.6M | $41.3M | $53.0M | -$151.4M |
| Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest | $136.2M | $187.4M | $80.9M | $78.3M | $131.1M | $157.2M | $43.6M | $36.8M | $51.5M | -$136.1M |
| Net Income Loss Attributable To Redeemable Noncontrolling Interest | $40.2M | $80.4M | $100.4M | -$17.2M | $69.3M | $120.2M | $9.1M | $4.5M | $1.5M | -$15.3M |
| Interest Expense | $4.9M | $4.7M | $5.6M | $5.4M | $6.0M | $5.7M | $5.3M | $5.2M | $5.5M | $4.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $180.3M | $270.5M | $184.5M | $64.1M | $202.9M | $277.9M | $55.0M | $44.2M | $54.6M | -$150.4M |
| Amortization Of Intangible Assets | $4.0M | $4.0M | $3.9M | $5.2M | $3.3M | $3.3M | $2.8M | $2.3M | $2.8M | $3.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.17B | $1.10B | $900.9M | $1.21B | $964.1M | $642.8M |
| Liability For Claims And Claims Adjustment Expense | $4.42B | $3.53B | $3.03B | $2.86B | $2.42B | $2.05B |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $1.26B | $1.01B | $714.6M | $758.3M | $56.7M | $44.9M |
| Deferred Policy Acquisition Cost Amortization Expense | $507.3M | $388.9M | $309.1M | $271.2M | $24.0M | $17.5M |
| Unrealized Gain Loss On Investments | $170.0M | $43.3M | $125.1M | -$165.3M | -$44.8M | |
| Gain Loss On Investments And Net Investment Income | $775.1M | $574.7M | $240.1M | $71.9M | -$36.7M | |
| Gain Loss On Investments | $687.1M | $511.4M | $209.6M | $93.3M | -$33.5M | |
| Stockholders Equity | $2.82B | $2.33B | $2.05B | $1.66B | $1.75B | $1.66B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $71.2M | $200.0M | -$306.3M | $243.1M | $9.2M | -$17.3M |
| Trading Securities Debt Amortized Cost | $3.41B | $2.92B | $2.29B | $1.63B | ||
| Trading Securities Debt | $3.44B | $2.87B | $2.26B | $1.55B | ||
| Retained Earnings Accumulated Deficit | $1.69B | $1.17B | $801.4M | $547.4M | ||
| Restricted Cash And Cash Equivalents | $109.7M | $104.4M | $106.4M | $130.8M | ||
| Reinsurance Payable | $296.4M | $261.3M | $272.3M | $244.3M | ||
| Redeemable Noncontrolling Interest Equity Carrying Amount | $172.0K | $128.0K | $133.0K | $119.0K | ||
| Receivables From Brokers Dealers And Clearing Organizations | $58.0M | $74.0M | $42.4M | $371.0K | ||
| Premiums Receivable At Carrying Value | $939.8M | $771.7M | $658.4M | $522.7M | ||
| Payables To Broker Dealers And Clearing Organizations | $209.9M | $115.4M | $66.6M | $48.1M | ||
| Other Liabilities | $123.4M | $100.4M | $6.5M | $20.0K | ||
| Other Assets | $265.4M | $208.6M | $209.6M | $167.5M | ||
| Long Term Debt | $149.7M | $149.9M | $149.8M | $149.7M | ||
| Liabilities And Stockholders Equity | $9.57B | $7.80B | $6.67B | $5.82B | ||
| Liabilities | $6.75B | $5.47B | $4.62B | $4.15B | ||
| Investments | $5.03B | $3.81B | $3.11B | $2.29B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.07B | $1.07B | $913.1M | $1.05B | $1.11B | $1.18B | $903.5M | $925.2M | $1.08B | $1.35B |
| Liability For Claims And Claims Adjustment Expense | $4.21B | $3.98B | $3.82B | $3.43B | $3.24B | $3.15B | $2.95B | $2.90B | $2.89B | $2.76B |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $278.7M | $269.9M | $395.2M | $273.6M | $214.5M | $232.4M | $191.6M | $179.4M | $148.6M | $258.0M |
| Deferred Policy Acquisition Cost Amortization Expense | $125.4M | $122.8M | $116.9M | $102.2M | $96.3M | $84.6M | $78.5M | $76.9M | $65.1M | $65.7M |
| Unrealized Gain Loss On Investments | $5.8M | $11.9M | $130.1M | -$45.5M | $11.8M | $105.9M | $4.9M | -$8.2M | $72.8M | -$182.5M |
| Gain Loss On Investments And Net Investment Income | $137.9M | $229.1M | $267.7M | $65.6M | $165.0M | $268.0M | $55.4M | $26.7M | $37.5M | -$72.6M |
| Gain Loss On Investments | $115.1M | $208.0M | $248.8M | $48.2M | $151.3M | $255.4M | $47.3M | $19.4M | $35.1M | -$67.4M |
| Stockholders Equity | $2.66B | $2.56B | $2.40B | $2.31B | $2.24B | $2.21B | $1.80B | $1.75B | $1.72B | $1.72B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$187.8M | $279.7M | -$122.4M | |||||||
| Trading Securities Debt Amortized Cost | $3.25B | $2.99B | $2.84B | $2.81B | $2.58B | $2.28B | $2.08B | |||
| Trading Securities Debt | $3.27B | $3.01B | $2.83B | $2.83B | $2.53B | $2.23B | $1.98B | |||
| Retained Earnings Accumulated Deficit | $1.53B | $1.41B | $1.24B | $1.14B | $1.07B | $957.8M | $674.6M | |||
| Restricted Cash And Cash Equivalents | $110.1M | $85.6M | $74.5M | $93.9M | $98.3M | $95.6M | $99.0M | |||
| Reinsurance Payable | $372.7M | $417.3M | $346.2M | $334.5M | $399.6M | $367.1M | $368.0M | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | $81.2M | $69.3M | $39.2M | $60.1M | $77.3M | $54.7M | $129.0K | |||
| Receivables From Brokers Dealers And Clearing Organizations | $45.2M | $38.3M | $46.4M | $39.1M | $12.3M | $17.8M | $19.0M | |||
| Premiums Receivable At Carrying Value | $1.01B | $1.05B | $989.7M | $885.7M | $933.2M | $856.1M | $689.0M | |||
| Payables To Broker Dealers And Clearing Organizations | $102.0M | $127.5M | $46.9M | $172.9M | $111.3M | $55.1M | $117.8M | |||
| Other Liabilities | $28.3M | $50.2M | $70.7M | $0.00 | $43.0M | $75.8M | $9.1M | |||
| Other Assets | $217.2M | $222.7M | $231.0M | $192.5M | $201.3M | $205.2M | $164.0M | |||
| Long Term Debt | $149.7M | $149.7M | $150.0M | $149.9M | $149.9M | $149.9M | $149.8M | |||
| Liabilities And Stockholders Equity | $9.21B | $8.91B | $8.34B | $7.83B | $7.62B | $7.35B | $6.50B | |||
| Liabilities | $6.47B | $6.29B | $5.90B | $5.45B | $5.31B | $5.08B | $4.70B | |||
| Investments | $4.77B | $4.46B | $4.17B | $3.76B | $3.46B | $3.18B | $2.96B |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Increase Decrease In Unearned Premiums Net | -$177.8M | -$186.4M | -$161.9M | -$78.2M | $710.0K | |
| Net Cash Provided By Used In Operating Activities | $842.4M | $759.3M | $283.2M | $190.9M | -$33.9M | -$20.8M |
| Net Cash Provided By Used In Investing Activities | -$414.1M | -$184.2M | -$652.1M | $133.1M | $43.1M | $2.1M |
| Net Cash Provided By Used In Financing Activities | -$376.2M | -$362.7M | $59.0M | -$69.6M | -$23.0K | -$53.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.1M | -$12.5M | $3.6M | -$11.3M | $46.0K | $1.4M |
| Share Based Compensation | $29.3M | $30.4M | $44.4M | $10.8M | $1.0M | |
| Proceeds From Sale Of Short Term Investments | $1.42B | $1.80B | $1.39B | $1.84B | $413.1M | |
| Proceeds From Sale Of Other Investments | $2.65B | $2.87B | $2.59B | $2.59B | $184.5M | |
| Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment | $1.71B | $1.38B | $689.0M | $420.7M | $51.4M | |
| Proceeds From Payments For From Contributions To Additional Paid In Capital | -$26.0K | $370.0K | $82.9M | $308.0K | $0.00 | |
| Proceeds From Issuance Of Common Stock | $25.0K | $26.0K | $73.0K | $7.0K | $0.00 | |
| Payments To Minority Shareholders | $263.3M | $212.7M | $21.5M | $68.1M | $23.0K | |
| Payments To Acquire Trading Securities Heldforinvestment | $2.49B | $1.93B | $1.22B | $705.1M | $54.4M | |
| Payments To Acquire Short Term Investments | $1.10B | $1.83B | $1.51B | $1.55B | $357.9M | |
| Payments To Acquire Other Investments | $2.71B | $2.48B | $2.55B | $2.46B | $137.5M | |
| Payments For Repurchase Of Common Stock | $112.5M | $150.4M | $2.4M | $1.5M | $0.00 | |
| Payments For Proceeds From Other Investing Activities | $8.9M | $18.8M | $15.9M | $13.6M | $432.0K | |
| Increase Decrease In Unearned Premiums | $255.2M | $211.1M | $193.0M | $96.7M | $461.0K | |
| Increase Decrease In Reinsurance Recoverable Unpaid Losses And Loss Adjustment Expenses | $204.8M | $10.0M | -$16.8M | $65.3M | -$5.7M | |
| Increase Decrease In Reinsurance Recoverable Paid Claims And Claims Adjustments | -$40.7M | -$10.8M | $54.5M | $11.4M | $3.2M | |
| Increase Decrease In Reinsurance Payables | $35.1M | -$11.0M | $28.0M | -$42.5M | -$27.5M | |
| Increase Decrease In Prepaid Reinsurance Premiums | $77.4M | $24.6M | $30.0M | $11.8M | $603.0K | |
| Increase Decrease In Premiums Receivable | $168.1M | $113.3M | $135.7M | $60.4M | -$8.7M | |
| Increase Decrease In Other Operating Assets | $57.2M | -$1.2M | $42.7M | $41.9M | $21.5M | |
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $882.7M | $502.5M | $173.8M | $440.8M | $36.5M | |
| Increase Decrease In Deferred Policy Acquisition Costs | $48.2M | $52.1M | $41.7M | $16.3M | $2.7M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $14.9M | $92.5M | $55.3M | -$36.1M | -$29.4M | |
| Depreciation Amortization And Accretion Net | $15.9M | $16.5M | $12.4M | $15.0M | $961.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Unearned Premiums Net | -$56.0M | -$45.2M | -$104.9M | -$29.1M | -$56.3M | -$129.6M | -$46.5M | -$53.2M | -$64.6M | -$5.9M |
| Net Cash Provided By Used In Operating Activities | $34.9M | $158.2M | $12.1M | |||||||
| Net Cash Provided By Used In Investing Activities | -$150.6M | $194.1M | -$132.1M | |||||||
| Net Cash Provided By Used In Financing Activities | -$78.3M | -$68.4M | -$3.1M | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.1M | -$4.2M | $772.0K | |||||||
| Share Based Compensation | $6.6M | $7.3M | $2.4M | |||||||
| Proceeds From Sale Of Short Term Investments | $480.9M | $436.6M | $291.3M | |||||||
| Proceeds From Sale Of Other Investments | $719.5M | $837.8M | $733.3M | |||||||
| Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment | $424.2M | $387.1M | $158.2M | |||||||
| Proceeds From Payments For From Contributions To Additional Paid In Capital | -$11.0K | $387.0K | -$7.0K | |||||||
| Proceeds From Issuance Of Common Stock | $11.0K | $10.0K | $7.0K | |||||||
| Payments To Minority Shareholders | $61.4M | $65.6M | $1.5M | |||||||
| Payments To Acquire Trading Securities Heldforinvestment | $435.9M | $447.1M | $257.9M | |||||||
| Payments To Acquire Short Term Investments | $383.3M | $350.1M | $387.2M | |||||||
| Payments To Acquire Other Investments | $913.1M | $678.4M | $636.7M | |||||||
| Payments For Repurchase Of Common Stock | $16.9M | $3.2M | $1.6M | |||||||
| Payments For Proceeds From Other Investing Activities | $2.0M | $5.0M | $5.7M | |||||||
| Increase Decrease In Unearned Premiums | $215.2M | $221.3M | $153.1M | |||||||
| Increase Decrease In Reinsurance Recoverable Unpaid Losses And Loss Adjustment Expenses | $64.0M | $6.4M | $14.4M | |||||||
| Increase Decrease In Reinsurance Recoverable Paid Claims And Claims Adjustments | -$42.7M | $24.3M | -$18.6M | |||||||
| Increase Decrease In Reinsurance Payables | $85.0M | $94.8M | $69.0M | |||||||
| Increase Decrease In Prepaid Reinsurance Premiums | $110.3M | $91.7M | $87.4M | |||||||
| Increase Decrease In Premiums Receivable | $217.9M | $197.7M | $137.1M | |||||||
| Increase Decrease In Other Operating Assets | $22.7M | -$4.1M | $6.5M | |||||||
| Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | $282.8M | $118.7M | $35.2M | |||||||
| Increase Decrease In Deferred Policy Acquisition Costs | $33.4M | $34.0M | $20.9M | |||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$77.4M | $38.1M | -$20.1M | |||||||
| Depreciation Amortization And Accretion Net | $4.3M | $3.6M | $3.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 99.0M | 101.5M | 110.2M | 103.1M | 102.6M | 102.5M |
| Common Stock Shares Issued | 99.0M | 101.5M | 110.2M | 103.1M | 102.6M | 102.5M |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 135.0M | 135.0M | 135.0M |
| Earnings Per Share Diluted | $5.55 | $3.67 | $2.44 | $-0.95 | $-0.35 | $0.61 |
| Earnings Per Share Basic | $5.75 | $3.81 | $2.47 | $-0.95 | $-0.35 | $0.62 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 98.4M | 100.1M | 101.7M | 101.4M | 101.9M | 111.0M | 103.7M | 103.7M | 103.7M | 103.1M | 103.0M |
| Common Stock Shares Issued | 98.4M | 100.1M | 101.7M | 101.4M | 101.9M | 111.0M | 103.7M | 103.7M | 103.7M | 103.1M | 103.0M |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 135.0M | 135.0M | 135.0M | 135.0M |
| Earnings Per Share Diluted | $1.32 | $1.79 | $0.77 | $0.74 | $1.20 | $1.38 | $0.41 | $0.35 | $0.49 | $-1.32 | |
| Earnings Per Share Basic | $1.37 | $1.85 | $0.79 | $0.77 | $1.24 | $1.42 | $0.42 | $0.35 | $0.50 | $-1.32 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Reinsurance Recoverable For Unpaid Claims And Claims Adjustments | $1.38B | $1.17B | $1.16B | $1.18B | $1.11B | $1.08B |
| Premiums Earned Net | $2.11B | $1.73B | $1.32B | $1.14B | $98.6M | $67.5M |
| Benefits Losses And Expenses | $2.08B | $1.71B | $1.32B | $1.26B | $98.6M | $79.2M |
| Premiums Written Net | $2.29B | $1.92B | $1.48B | $1.22B | $97.9M | |
| Premiums Written Gross | $2.92B | $2.42B | $1.95B | $1.65B | $121.8M | |
| Other Income | $26.6M | $23.8M | $18.6M | $11.3M | $2.1M | |
| Investment Income Net | $88.0M | $63.3M | $30.5M | -$21.5M | -$3.2M | |
| Foreign Currency Transaction Gain Loss Before Tax | -$6.0M | -$3.2M | -$6.2M | $6.1M | $16.0K | |
| Ceded Premiums Written | $635.6M | $501.4M | $470.6M | $424.8M | $23.9M | |
| Realized Investment Gains Losses | $517.1M | $468.1M | $84.5M | $258.7M | ||
| Other Noncash Income Expense | $28.7M | -$3.8M | $6.5M | -$12.5M | $110.0K | |
| Unearned Premiums | $1.38B | $1.12B | $911.2M | $718.2M | ||
| Reinsurance Recoverables On Paid Losses | $93.7M | $134.4M | $145.2M | $90.7M | ||
| Prepaid Reinsurance Premiums | $296.4M | $218.9M | $194.3M | $164.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reinsurance Recoverable For Unpaid Claims And Claims Adjustments | $1.30B | $1.24B | $1.24B | $1.19B | $1.16B | $1.17B | $1.16B | $1.16B | $1.19B | $1.15B |
| Premiums Earned Net | $523.0M | $511.2M | $498.9M | $448.8M | $418.8M | $385.3M | $337.0M | $331.5M | $283.9M | $294.9M |
| Benefits Losses And Expenses | $487.4M | $470.3M | $584.3M | $448.8M | $385.1M | $380.7M | $341.2M | $313.0M | $267.8M | $377.3M |
| Premiums Written Net | $579.0M | $556.3M | $603.9M | $477.9M | $475.1M | $514.9M | $383.6M | $384.7M | $348.5M | $300.8M |
| Premiums Written Gross | $698.8M | $712.0M | $843.3M | $553.4M | $603.3M | $721.9M | $474.1M | $505.0M | $538.2M | $400.8M |
| Other Income | $4.2M | $5.0M | $4.7M | $4.5M | $6.0M | $7.5M | $2.4M | $2.4M | $3.0M | $2.7M |
| Investment Income Net | $22.7M | $21.1M | $18.9M | $17.3M | $13.7M | $12.6M | $8.1M | $7.3M | $2.4M | -$5.3M |
| Foreign Currency Transaction Gain Loss Before Tax | $2.6M | -$4.5M | -$2.5M | -$6.0M | -$1.8M | -$2.1M | $1.4M | -$3.3M | -$2.0M | $1.9M |
| Ceded Premiums Written | $119.9M | $155.7M | $239.4M | $75.5M | $128.2M | $207.1M | $90.6M | $120.3M | $189.7M | $100.0M |
| Realized Investment Gains Losses | $109.4M | $196.1M | $118.7M | $93.7M | $139.5M | $149.4M | $42.4M | $27.6M | -$37.7M | $115.1M |
| Other Noncash Income Expense | $8.5M | -$2.4M | $650.0K | |||||||
| Unearned Premiums | $1.44B | $1.41B | $1.34B | $1.19B | $1.20B | $1.13B | $951.6M | |||
| Reinsurance Recoverables On Paid Losses | $115.8M | $131.8M | $91.7M | $146.0M | $147.7M | $169.5M | $138.3M | |||
| Prepaid Reinsurance Premiums | $334.0M | $360.9M | $329.2M | $260.2M | $299.6M | $286.0M | $232.2M |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.